Review




Structured Review

Becton Dickinson rabbit anti-active caspase-3
A. The linear regression of mRNA expression of ALDOA in patient-derived melanoma cell lines correlated with the percentage of T cell-mediated tumor killing is shown. Patient-derived melanoma cell lines (n=12) overexpressing Gp100 and H-2Db, which can be recognized by Pmel T cells derived from the TCR transgenic Pmel-1 mouse, were generated by lentivirus-based genetic manipulations. Transduced melanoma cells were co-cultured with Pmel T cells at an effector to target ratio of 10:1 for 3 hours. The percentage of T cell-induced tumor killing was then calculated by quantifying the number of cleaved <t>caspase-3+</t> cells with respect to the total number of tumor cells by flow cytometry. The mRNA expression of glycolysis-related genes in patient-derived melanoma cells was determined by microarray analysis. The R and P-value of the correlation between the ALDOA expression and the sensitivity to T cell killing in this set of patient-derived melanoma cell lines are listed. B. Overexpression of ALDOA in melanoma cells promotes resistance to T cell-mediated tumor cell apoptosis. Patient-derived melanoma cells (Mel2400) were transduced with lentiviral vectors encoding either ALDOA-RFP or GFP-RFP. The percentage of cleaved caspase-3+ transduced melanoma cells (based on the expression of the reporter gene RFP) was determined by flow cytometry. C. The impaired effector function of TILs by lactic acid is shown. TILs (TIL2559) derived from a melanoma patient were treated overnight with different concentrations of lactic acid. *P<0.05 (with versus without lactic acid treatment) D. LDHAi increases T cell-induced killing of melanoma cells. Patient-derived melanoma cells (Mel2792) were pre-treated with 1 uM of GSK2837808A, and followed by co-culture with autologous TILs (TIL2792) for 4 hours. E. Targeting glycolysis pathway enhances the antitumor activity of T cells. B16 melanoma cells were implanted subcutaneously in C57BL/6 mice. Tumor-bearing mice were treated with either GSK2837808A (6 mg/kg) orally and/or adoptively transferred Pmel T cells. Mice treated with the relevant solvent were used as control. Tumor sizes were monitored by measuring the perpendicular diameters of the tumors and are shown as mean tumor area ± SEM. All experiments were carried out in a blinded, randomized fashion (n=4–5 mice per group). F. Kaplan-Maier plots show survivals of tumor-bearing mice treated with vehicle, GSK2837808A, T cell therapy and combination of GSK2837808A and T cell therapy (n=4–5 mice per group). *P<0.05, **P<0.01, and ****P<0.0001.
Rabbit Anti Active Caspase 3, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ht-12+expression+beadchip+v4+microarray/anti+caspase+3/pmc05932208-698-2-9
Average 90 stars, based on 1 article reviews
rabbit anti-active caspase-3 - by Bioz Stars, 2026-11
90/100 stars

Images

1) Product Images from "Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T cell Therapy"

Article Title: Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T cell Therapy

Journal: Cell metabolism

doi: 10.1016/j.cmet.2018.02.024

A. The linear regression of mRNA expression of ALDOA in patient-derived melanoma cell lines correlated with the percentage of T cell-mediated tumor killing is shown. Patient-derived melanoma cell lines (n=12) overexpressing Gp100 and H-2Db, which can be recognized by Pmel T cells derived from the TCR transgenic Pmel-1 mouse, were generated by lentivirus-based genetic manipulations. Transduced melanoma cells were co-cultured with Pmel T cells at an effector to target ratio of 10:1 for 3 hours. The percentage of T cell-induced tumor killing was then calculated by quantifying the number of cleaved caspase-3+ cells with respect to the total number of tumor cells by flow cytometry. The mRNA expression of glycolysis-related genes in patient-derived melanoma cells was determined by microarray analysis. The R and P-value of the correlation between the ALDOA expression and the sensitivity to T cell killing in this set of patient-derived melanoma cell lines are listed. B. Overexpression of ALDOA in melanoma cells promotes resistance to T cell-mediated tumor cell apoptosis. Patient-derived melanoma cells (Mel2400) were transduced with lentiviral vectors encoding either ALDOA-RFP or GFP-RFP. The percentage of cleaved caspase-3+ transduced melanoma cells (based on the expression of the reporter gene RFP) was determined by flow cytometry. C. The impaired effector function of TILs by lactic acid is shown. TILs (TIL2559) derived from a melanoma patient were treated overnight with different concentrations of lactic acid. *P<0.05 (with versus without lactic acid treatment) D. LDHAi increases T cell-induced killing of melanoma cells. Patient-derived melanoma cells (Mel2792) were pre-treated with 1 uM of GSK2837808A, and followed by co-culture with autologous TILs (TIL2792) for 4 hours. E. Targeting glycolysis pathway enhances the antitumor activity of T cells. B16 melanoma cells were implanted subcutaneously in C57BL/6 mice. Tumor-bearing mice were treated with either GSK2837808A (6 mg/kg) orally and/or adoptively transferred Pmel T cells. Mice treated with the relevant solvent were used as control. Tumor sizes were monitored by measuring the perpendicular diameters of the tumors and are shown as mean tumor area ± SEM. All experiments were carried out in a blinded, randomized fashion (n=4–5 mice per group). F. Kaplan-Maier plots show survivals of tumor-bearing mice treated with vehicle, GSK2837808A, T cell therapy and combination of GSK2837808A and T cell therapy (n=4–5 mice per group). *P<0.05, **P<0.01, and ****P<0.0001.
Figure Legend Snippet: A. The linear regression of mRNA expression of ALDOA in patient-derived melanoma cell lines correlated with the percentage of T cell-mediated tumor killing is shown. Patient-derived melanoma cell lines (n=12) overexpressing Gp100 and H-2Db, which can be recognized by Pmel T cells derived from the TCR transgenic Pmel-1 mouse, were generated by lentivirus-based genetic manipulations. Transduced melanoma cells were co-cultured with Pmel T cells at an effector to target ratio of 10:1 for 3 hours. The percentage of T cell-induced tumor killing was then calculated by quantifying the number of cleaved caspase-3+ cells with respect to the total number of tumor cells by flow cytometry. The mRNA expression of glycolysis-related genes in patient-derived melanoma cells was determined by microarray analysis. The R and P-value of the correlation between the ALDOA expression and the sensitivity to T cell killing in this set of patient-derived melanoma cell lines are listed. B. Overexpression of ALDOA in melanoma cells promotes resistance to T cell-mediated tumor cell apoptosis. Patient-derived melanoma cells (Mel2400) were transduced with lentiviral vectors encoding either ALDOA-RFP or GFP-RFP. The percentage of cleaved caspase-3+ transduced melanoma cells (based on the expression of the reporter gene RFP) was determined by flow cytometry. C. The impaired effector function of TILs by lactic acid is shown. TILs (TIL2559) derived from a melanoma patient were treated overnight with different concentrations of lactic acid. *P<0.05 (with versus without lactic acid treatment) D. LDHAi increases T cell-induced killing of melanoma cells. Patient-derived melanoma cells (Mel2792) were pre-treated with 1 uM of GSK2837808A, and followed by co-culture with autologous TILs (TIL2792) for 4 hours. E. Targeting glycolysis pathway enhances the antitumor activity of T cells. B16 melanoma cells were implanted subcutaneously in C57BL/6 mice. Tumor-bearing mice were treated with either GSK2837808A (6 mg/kg) orally and/or adoptively transferred Pmel T cells. Mice treated with the relevant solvent were used as control. Tumor sizes were monitored by measuring the perpendicular diameters of the tumors and are shown as mean tumor area ± SEM. All experiments were carried out in a blinded, randomized fashion (n=4–5 mice per group). F. Kaplan-Maier plots show survivals of tumor-bearing mice treated with vehicle, GSK2837808A, T cell therapy and combination of GSK2837808A and T cell therapy (n=4–5 mice per group). *P<0.05, **P<0.01, and ****P<0.0001.

Techniques Used: Expressing, Derivative Assay, Transgenic Assay, Generated, Cell Culture, Flow Cytometry, Microarray, Over Expression, Transduction, Co-Culture Assay, Activity Assay

Related Articles

other:

Article Title: Cancer cell-selective induction of mitochondrial stress and immunogenic cell death by PT-112 in human prostate cell lines.
Article Snippet: Caspase-3 activation was measured using a FITC-labelled antibody against cleaved caspase-3 (BD PharmingenTM, Madrid, Spain).

Article Title: A dual-STING-activating nanosystem expands cancer immunotherapeutic temporal window
Article Snippet: FITC anti-mouse Caspase 3 (clone C92-605) , BD , Cat: 559341; RRID: AB_397234.

Article Title: Nanoparticles containing intracellular proteins modulate neutrophil functional and phenotypic heterogeneity
Article Snippet: Then, active caspase 3 was stained according to the manufacturer’s instructions (FITC Active Caspase-3 Apoptosis Kit, Becton Dickinson, USA).

Article Title: Neuroprotective effects of G9a inhibition through modulation of peroxisome-proliferator activator receptor gamma-dependent pathways by miR-128
Article Snippet: Caspase-3 , Rabbit , BD Transduction Laboratories/C31720/AB_2335903 , 1:1000.

Article Title: LKB1 regulates ILC3 postnatal development and effector function through metabolic programming
Article Snippet: For apoptosis assay analyses, cells were stained with anti- active Caspase 3 antibodies (BD HorizonTM Clone: C92-605) according to the manufacturer’s instructions.

Article Title: Nanoparticles containing intracellular proteins modulate neutrophil functional and phenotypic heterogeneity
Article Snippet: FITC Active Caspase-3 Apoptosis Kit Becton Dickinson 550480 Mouse Inflammation, Cytometric Bead Array Kit Becton Dickinson 552364 PE Active Caspase-3 Apoptosis Kit Becton Dickinson 550914 PierceTM Chromogenic Endotoxin Quant Kit Thermo Fisher Scientific A39552 Substances and commercially available solutions 0,4% Trypan Blue Sigma Aldrich (Germany) T8154 L-Glutamine Thermo Fisher Scientific 11140050 10X Phosphate Buffered Saline Thermo Fisher Scientific AM9625 16% Formaldehyde Thermo Fisher Scientific 28906 2-Mercaptoethanol Sigma Aldrich (Germany) M6250 2-Propanol Carl Roth (Germany) CN09.1 4-12% Bis-Tris Midi Protein Gels, 20 well Thermo Fisher Scientific WG1402BOX Acetic Acid Thermo Fisher Scientific 036289.K3 Acetic Acid Carl Roth (Germany) Cat# 64-19-7 Amido black 10 B Merck (Germany) 1041870025 Ammonium chloride Sigma Aldrich (Germany) 254134 Bovine Serum Albumin Thermo Fisher Scientific B14 Bovine Serum Albumin Sigma Aldrich (Germany) A9418 Bromophenol blue Carl Roth (Germany) T116.1 Chloroform Carl Roth (Germany) 3313.2 Coomassie Brilliant Blue Sigma Aldrich (Germany) 115.444 Crystal Violet Sigma Aldrich (Germany) 548-62-9 Dimethyl Sulfoxide Sigma Aldrich (Germany) 67-68-5 Dulbecco’s Modified Eagle’s Medium Sigma Aldrich (Germany) D5796 Dulbecco’s Phosphate Buffered Saline, with MgCl2 and CaCl2 Sigma Aldrich (Germany) D8662 Dulbecco’s Phosphate-Buffered Saline Corning (USA) 21-031-CV Dulbecco’s Phosphate-Buffered Saline Sigma Aldrich (Germany) D8537 EDTA disodium salt solution Sigma Aldrich (Germany) E7889 Ethanol DeconTM Laboratories, Inc. 2716 Fetal Bovine Serum Thermo Fisher Scientific A5256701 Fetal Bovine Serum Sigma Aldrich (Germany) F0850 Gentamicin 10mg/mL Thermo Fisher Scientific 15710064 Hanks’ Balanced Salt Solution, no calcium, no magnesium Thermo Fisher Scientific 14170120 HEPES Carl Roth (Germany) 6763.3 HEPES 1M Sigma Aldrich (Germany) H0887 Hydrochloric Acid Thermo Fisher Scientific L13091.AU Hydrochloric Acid Carl Roth (Germany) 4328.3 Immersion Oil Carl Zeiss (Germany) 10539438 Isopropanol Th.

Article Title: Osthole's capacity to prevent tau aggregation, a key protein in tauopathy and Alzheimer's disease.
Article Snippet: Aggregated forms of protein arising from misfolded variants under physiological conditions can lead to the development of disorders related to proteinopathy, including Alzheimer’s disease (AD).. Some small molecules derived from plants can enhance the process of protein disaggregation via various pathways.. Among the different bioactive substances, osthole—a natural coumarin compound—can be highly effective against protein aggregation and associated proteinopathies.

Staining:

Article Title: Selisistat, a SIRT1 inhibitor, enhances paclitaxel activity in luminal and triple-negative breast cancer: in silico, in vitro, and in vivo studies.
Article Snippet: For this purpose, t47D, McF7, MDa-MB-231, MDa-MB-468 and Bt-549 cells at 70% confluence were seeded in 6-well plates (Nunc) at a density of 1 × 105/ml and cultured overnight before incubation with different concentrations of eX527 and PaX used alone or in combination for 48 h. then, cells were harvested and washed twice with ice-cold PBs. after resuspending, the cells were fixed and permeabilized using the cytofix/cytoperm solution according to the manufacturer’s protocol of Pe active caspase-3 apoptosis Kit (BD Pharmingen; san Diego, ca, Usa, catalogue number aB_393957). .. Finally, cells were washed in the Perm/Wash Buffer before intracellular staining with Pe-conjugated anti-active caspase-3 monoclonal rabbit antibody (BD Pharmingen; catalogue number aB_393957). labelled cells were analysed by flow cytometer FacscaliburtM (Becton Dickinson; san Jose, ca, Usa), operating with cellQuest software to quantitatively assess the caspase-3 activity. ..

Flow Cytometry:

Article Title: Selisistat, a SIRT1 inhibitor, enhances paclitaxel activity in luminal and triple-negative breast cancer: in silico, in vitro, and in vivo studies.
Article Snippet: For this purpose, t47D, McF7, MDa-MB-231, MDa-MB-468 and Bt-549 cells at 70% confluence were seeded in 6-well plates (Nunc) at a density of 1 × 105/ml and cultured overnight before incubation with different concentrations of eX527 and PaX used alone or in combination for 48 h. then, cells were harvested and washed twice with ice-cold PBs. after resuspending, the cells were fixed and permeabilized using the cytofix/cytoperm solution according to the manufacturer’s protocol of Pe active caspase-3 apoptosis Kit (BD Pharmingen; san Diego, ca, Usa, catalogue number aB_393957). .. Finally, cells were washed in the Perm/Wash Buffer before intracellular staining with Pe-conjugated anti-active caspase-3 monoclonal rabbit antibody (BD Pharmingen; catalogue number aB_393957). labelled cells were analysed by flow cytometer FacscaliburtM (Becton Dickinson; san Jose, ca, Usa), operating with cellQuest software to quantitatively assess the caspase-3 activity. ..

Software:

Article Title: Selisistat, a SIRT1 inhibitor, enhances paclitaxel activity in luminal and triple-negative breast cancer: in silico, in vitro, and in vivo studies.
Article Snippet: For this purpose, t47D, McF7, MDa-MB-231, MDa-MB-468 and Bt-549 cells at 70% confluence were seeded in 6-well plates (Nunc) at a density of 1 × 105/ml and cultured overnight before incubation with different concentrations of eX527 and PaX used alone or in combination for 48 h. then, cells were harvested and washed twice with ice-cold PBs. after resuspending, the cells were fixed and permeabilized using the cytofix/cytoperm solution according to the manufacturer’s protocol of Pe active caspase-3 apoptosis Kit (BD Pharmingen; san Diego, ca, Usa, catalogue number aB_393957). .. Finally, cells were washed in the Perm/Wash Buffer before intracellular staining with Pe-conjugated anti-active caspase-3 monoclonal rabbit antibody (BD Pharmingen; catalogue number aB_393957). labelled cells were analysed by flow cytometer FacscaliburtM (Becton Dickinson; san Jose, ca, Usa), operating with cellQuest software to quantitatively assess the caspase-3 activity. ..

Activity Assay:

Article Title: Selisistat, a SIRT1 inhibitor, enhances paclitaxel activity in luminal and triple-negative breast cancer: in silico, in vitro, and in vivo studies.
Article Snippet: For this purpose, t47D, McF7, MDa-MB-231, MDa-MB-468 and Bt-549 cells at 70% confluence were seeded in 6-well plates (Nunc) at a density of 1 × 105/ml and cultured overnight before incubation with different concentrations of eX527 and PaX used alone or in combination for 48 h. then, cells were harvested and washed twice with ice-cold PBs. after resuspending, the cells were fixed and permeabilized using the cytofix/cytoperm solution according to the manufacturer’s protocol of Pe active caspase-3 apoptosis Kit (BD Pharmingen; san Diego, ca, Usa, catalogue number aB_393957). .. Finally, cells were washed in the Perm/Wash Buffer before intracellular staining with Pe-conjugated anti-active caspase-3 monoclonal rabbit antibody (BD Pharmingen; catalogue number aB_393957). labelled cells were analysed by flow cytometer FacscaliburtM (Becton Dickinson; san Jose, ca, Usa), operating with cellQuest software to quantitatively assess the caspase-3 activity. ..



Similar Products

90
Illumina Inc whole human genome microarray human ht-12 v4 expression beadchip
Whole Human Genome Microarray Human Ht 12 V4 Expression Beadchip, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ht-12+expression+beadchip+v4+microarray/illumina+arrays/pmc09913703-52-13-19
Average 90 stars, based on 1 article reviews
whole human genome microarray human ht-12 v4 expression beadchip - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Illumina Inc microarray chips human ht-12 v4 expression beadchips
Microarray Chips Human Ht 12 V4 Expression Beadchips, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ht-12+expression+beadchip+v4+microarray/illumina+arrays/us11441187-474-13-20
Average 90 stars, based on 1 article reviews
microarray chips human ht-12 v4 expression beadchips - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Illumina Inc ht-12 expression beadchip v4 microarray
Ht 12 Expression Beadchip V4 Microarray, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ht-12+expression+beadchip+v4+microarray/illumina+arrays/pm30826443-1-37-36
Average 90 stars, based on 1 article reviews
ht-12 expression beadchip v4 microarray - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Illumina Inc ht-12 v4 expression beadchip microarrays
Ht 12 V4 Expression Beadchip Microarrays, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ht-12+expression+beadchip+v4+microarray/illumina+arrays/pmc07108734-139-6-5
Average 90 stars, based on 1 article reviews
ht-12 v4 expression beadchip microarrays - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Illumina Inc human ht-12 v4 expression beadchip microarray system
Human Ht 12 V4 Expression Beadchip Microarray System, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ht-12+expression+beadchip+v4+microarray/illumina+arrays/pm29143560-318-19-26
Average 90 stars, based on 1 article reviews
human ht-12 v4 expression beadchip microarray system - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Illumina Inc human ht-12 v4 expression beadchip microarrays
Human Ht 12 V4 Expression Beadchip Microarrays, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ht-12+expression+beadchip+v4+microarray/illumina+arrays/pmc06826139-138-7-13
Average 90 stars, based on 1 article reviews
human ht-12 v4 expression beadchip microarrays - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Illumina Inc microarray gene expression platform beadchip human-ht-12 v4
Microarray Gene Expression Platform Beadchip Human Ht 12 V4, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ht-12+expression+beadchip+v4+microarray/human+ht+12+48+k+bead+chip/pmc06628831-484-23-28
Average 90 stars, based on 1 article reviews
microarray gene expression platform beadchip human-ht-12 v4 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Illumina Inc expression microarray illumina ht-12 v4 expression beadchip
Expression Microarray Illumina Ht 12 V4 Expression Beadchip, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ht-12+expression+beadchip+v4+microarray/illumina+arrays/pmc05788706-212-15-20
Average 90 stars, based on 1 article reviews
expression microarray illumina ht-12 v4 expression beadchip - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Illumina Inc microarray analysis illumina human ht-12 v4 expression beadchip
Microarray Analysis Illumina Human Ht 12 V4 Expression Beadchip, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ht-12+expression+beadchip+v4+microarray/illumina+arrays/pmc06531304-66-10-20
Average 90 stars, based on 1 article reviews
microarray analysis illumina human ht-12 v4 expression beadchip - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results